FINANCIAL POST
The partnership signals the first deal between a major pharmaceutical company and a Canadian cannabis producer.
FINANCIAL POST
The partnership signals the first deal between a major pharmaceutical company and a Canadian cannabis producer.
THE GLOBE AND MAIL
Tilray has raised $60-million to expand its growing capacity in Canada and Europe and to push its brand of medical cannabis products into a handful of new countries.
CBC NEWS
Following Germany, several other European countries, including Greece, Italy, Poland and the Czech Republic, passed new medical cannabis laws. That's led Tilray to begin construction of a $30-million production facility in Portugal to help supply the growing market.
PBS NEWSHOUR
PBS speaks to neuroscientist Catherine Jacobson, who heads clinical research for Tilray, about how the company is trying to turn cannabis into conventional medicine.